Folgen
Matthias Cavassini
Matthias Cavassini
Head of the Infectious Diseases outpatient clinic, CHUV, Lausanne, Switzerland
Bestätigte E-Mail-Adresse bei chuv.ch
Titel
Zitiert von
Zitiert von
Jahr
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
Archives of internal medicine 166 (15), 1632-1641, 2006
14862006
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
11552008
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
A Trickey, MT May, JJ Vehreschild, N Obel, MJ Gill, HM Crane, ...
The lancet HIV 4 (8), e349-e356, 2017
10862017
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
S Simioni, M Cavassini, JM Annoni, AR Abraham, I Bourquin, V Schiffer, ...
Aids 24 (9), 1243-1250, 2010
8892010
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
B Hasse, B Ledergerber, H Furrer, M Battegay, B Hirschel, M Cavassini, ...
Clinical infectious diseases 53 (11), 1130-1139, 2011
7482011
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
5722008
Decreasing mortality and changing patterns of causes of death in the S wiss HIV C ohort S tudy
R Weber, M Ruppik, M Rickenbach, A Spörri, H Furrer, M Battegay, ...
HIV medicine 14 (4), 195-207, 2013
4862013
Dominant TNF-α+Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease
A Harari, V Rozot, FB Enders, M Perreau, JM Stalder, LP Nicod, ...
Nature medicine 17 (3), 372-376, 2011
4812011
PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals
R Banga, FA Procopio, A Noto, G Pollakis, M Cavassini, K Ohmiti, ...
Nature medicine 22 (7), 754-761, 2016
4702016
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
4352010
Characteristics, Determinants, and clinical relevance of CD4 T cell recovery to< 500 cells/µL in HIV type 1—infected individuals receiving potent antiretroviral therapy
GR Kaufmann, H Furrer, B Ledergerber, L Perrin, M Opravil, P Vernazza, ...
Clinical infectious diseases 41 (3), 361-372, 2005
4332005
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active …
A Mills, JR Arribas, J Andrade-Villanueva, G DiPerri, J Van Lunzen, ...
The Lancet Infectious Diseases 16 (1), 43-52, 2016
3592016
Changing patterns of cancer incidence in the early-and late-HAART periods: the Swiss HIV Cohort Study
S Franceschi, M Lise, GM Clifford, M Rickenbach, F Levi, M Maspoli, ...
British journal of cancer 103 (3), 416-422, 2010
3492010
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study
B Ledergerber, H Furrer, M Rickenbach, R Lehmann, L Elzi, B Hirschel, ...
Clinical Infectious Diseases 45 (1), 111-119, 2007
3222007
Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV‐infected Individuals
M Rotger, H Tegude, S Colombo, M Cavassini, H Furrer, L Decosterd, ...
Clinical pharmacology & therapeutics 81 (4), 557-566, 2007
3192007
Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America
M Helleberg, MT May, SM Ingle, F Dabis, P Reiss, G Fätkenheuer, ...
Aids 29 (2), 221-229, 2015
2902015
Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral …
FA Post, GJ Moyle, HJ Stellbrink, P Domingo, D Podzamczer, M Fisher, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (1), 49-57, 2010
2892010
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population
A Gueler, A Moser, A Calmy, HF Günthard, E Bernasconi, H Furrer, ...
Aids 31 (3), 427-436, 2017
2882017
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
J Ananworanich, A Gayet-Ageron, M Le Braz, W Prasithsirikul, ...
The Lancet 368 (9534), 459-465, 2006
2852006
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
2822005
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20